Clinical trials: Pharmacist Intervention
Chronic Disease
Cost-benefit Analysis of a Clinical Pharmacist Intervention
Clinical pharmacy services are vital in the prevention of adverse drug events (ADEs) in clinical practice, extending beyond the hospital to chronic disease management in outpatient settings.
- Trial name
- NCT03803033
- Testing
- Clinical pharmacy-based home medication management review service
- Where
- Jordan
- Volunteers
- 97 people, healthy volunteers welcome
- Sponsor
- Applied Science Private University
Polypharmacy
Bundled Hyperpolypharmacy Deprescribing
Older patients using many prescription drugs (hyperpolypharmacy) may be at increased risk of adverse drug effects. This randomized controlled trial tested the effectiveness and safety of a quality intervention intended to reduce…
- Trial name
- NCT05616689
- Testing
- Bundled hyperpolypharmacy
- Where
- United States
- Volunteers
- 2,471 people, healthy volunteers welcome
- Sponsor
- Kaiser Permanente
Drug Use
Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients >75 years. The intervention targets the transfer between hospital and primary care.
- Trial name
- NCT03671629
- Testing
- Enhanced clinical pharmacist service
- Where
- Sweden
- Volunteers
- 700 people, healthy volunteers welcome
- Sponsor
- Umeå University
Adherence, Medication
Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication
Boston Medical Center provides care to cancer patients on oral cancer medications through the use of Boston Medical Center Specialty Pharmacy (BMC SP).
- Trial name
- BSPAP (NCT03104114)
- Testing
- pharmacist-intervention, Historical control
- Where
- United States
- Volunteers
- 216 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Bias, Implicit, HIV
Intervention to Reduce Implicit Bias in Pharmacies
This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to prescribe PrEP.
- Conditions
- Bias, Implicit, HIV, Pre-exposure Prophylaxis
- Trial name
- NCT06487351
- Testing
- The adapted PHBI, The NIH Implicit Bias course
- Where
- United States
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Readmission, Hospital
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes.
- Trial name
- NCT00332514
- Testing
- telephone call by a pharmacist
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Medication Adherence
Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications
The 4-arm factorial design RCT tested the impact of a behavioral intervention (SBI or BI), a reminder device (Pillbox), and the combination of the two on adherence in adult patients who filled a prescription for oral medications…
- Trial name
- ECO-PHIL (NCT02604901)
- Testing
- Screening and Brief Intervention (BI), Pill Box (PB)
- Where
- 2 sites in United States
- Volunteers
- 1,091 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Diabetes Mellitus, Type 2
Pharmacist-led Intervention in Treatment Non-adherence in Southwestern Nigeria
Summary of the Research Medication non-adherence has a huge economic impact on the patient and the society at large. World Health Organization (WHO) has suggested that noncompliance with medication is a common problem which often…
- Trial name
- NCT04712916
- Testing
- Health education
- Where
- Nigeria
- Volunteers
- 401 people, healthy volunteers welcome
- Sponsor
- University of Ibadan
Intervention Study
Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered
- Trial name
- NCT03182972
- Testing
- Medication reconciliation
- Where
- 2 sites in Nigeria
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- University of Ibadan
Hypertension, Diabete Type 2
Pharmacists Interventions on Patients Diabetic, and Obese Patients in the UAE: Randomized Controlled Trials.
Hypertension, diabetes, and obesity are considered major risk factors for cardiovascular diseases and premature mortality worldwide. Furthermore, they have severe consequences on quality of life among patients.
- Conditions
- Hypertension, Diabete Type 2, Obesity, Pharmacist-Patient Relations
- Trial name
- NCT05488002
- Testing
- Pharmaceutical intervention
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- University of Sharjah